Gastroenterology Department, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer, (DIBAPS), University of Barcelona, Barcelona, Spain.
Clin Cancer Res. 2010 Nov 15;16(22):5402-13. doi: 10.1158/1078-0432.CCR-10-1491. Epub 2010 Oct 5.
Early-onset colorectal cancer (CRC) is suggestive of a hereditary predisposition. Lynch syndrome is the most frequent CRC hereditary cause. The MUTYH gene has also been related to hereditary CRC. A systematic characterization of these two diseases has not been reported previously in this population.
We studied a retrospectively collected series of 140 patients ≤50 years old diagnosed with nonpolyposis CRC. Demographic, clinical, and familial features were obtained. Mismatch repair (MMR) deficiency was determined by microsatellite instability (MSI) analysis, and immunostaining for MLH1, MSH2, MSH6, and PMS2 proteins. Germline MMR mutations were evaluated in all MMR-deficient cases. Tumor samples with loss of MLH1 or MSH2 protein expression were analyzed for somatic methylation. Germline MUTYH mutations were evaluated in all cases. BRAF V600E and KRAS somatic mutational status was also determined.
Fifteen tumors (11.4%) were MSI, and 20 (14.3%) showed loss of protein expression (7 for MLH1/PMS2, 2 for isolated MLH1, 3 for MSH2/MSH6, 7 for isolated MSH6, and 1 for MSH6/PMS2). We identified 11 (7.8%) germline MMR mutations, 4 in MLH1, 1 in MSH2, and 6 in MSH6. Methylation analysis revealed one case with somatic MLH1 methylation. Biallelic MUTYH mutations were detected in four (2.8%) cases. KRAS and BRAF V600E mutations were present in 39 (27.9%) and 5 (3.6%) cases, respectively.
Loss of MSH6 expression is the predominant cause of MMR deficiency in early-onset CRC. Our findings prompt the inclusion of MSH6 and MUTYH screening as part of the genetic counseling of these patients and their relatives.
早发性结直肠癌(CRC)提示存在遗传易感性。林奇综合征是 CRC 最常见的遗传性病因。MUTYH 基因也与遗传性 CRC 有关。在该人群中,尚未有关于这两种疾病的系统特征描述。
我们研究了一组 140 例≤50 岁的非息肉性 CRC 患者的回顾性系列。获取了人口统计学、临床和家族特征。通过微卫星不稳定性(MSI)分析和 MLH1、MSH2、MSH6 和 PMS2 蛋白免疫染色确定错配修复(MMR)缺陷。所有 MMR 缺陷病例均评估了种系 MMR 突变。对 MLH1 或 MSH2 蛋白表达缺失的肿瘤样本进行体细胞甲基化分析。所有病例均评估了种系 MUTYH 突变。还确定了 BRAF V600E 和 KRAS 体细胞突变状态。
15 例(11.4%)肿瘤为 MSI,20 例(14.3%)显示蛋白表达缺失(7 例为 MLH1/PMS2,2 例为 MLH1 单独缺失,3 例为 MSH2/MSH6,7 例为 MSH6 单独缺失,1 例为 MSH6/PMS2)。我们鉴定出 11 例(7.8%)种系 MMR 突变,4 例在 MLH1 中,1 例在 MSH2 中,6 例在 MSH6 中。体细胞 MLH1 甲基化分析显示 1 例。4 例(2.8%)存在双等位基因 MUTYH 突变。KRAS 和 BRAF V600E 突变分别存在于 39 例(27.9%)和 5 例(3.6%)病例中。
MSH6 表达缺失是早发性 CRC 中 MMR 缺陷的主要原因。我们的发现提示应将 MSH6 和 MUTYH 筛查纳入这些患者及其亲属的遗传咨询中。